VEGF signaling mediates bladder neuroplasticity and inflammation in response to BCG

BMC Physiology

Volumn 11, Issue 1, 2011, Pages

  Saban, Marcia R ^a   Davis, Carole A ^a   Avelino, Antonio ^b   Cruz, Francisco ^c   Maier, Julie ^d   Bjorling, Dale E ^e   Sferra, Thomas J ^a   Hurst, Robert E ^a   Saban, Ricardo ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PORTO   (Portugal)

^c HOSPITAL DE SÃO JOÃO   (Portugal)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CALCITONIN; NEUROPILIN; NEUROPILIN 1; NEUROPILIN 2; NEUTRALIZING ANTIBODY; PGP9.5 PROTEIN, MOUSE; PROCALCITONIN; PROTEIN PRECURSOR; RECOMBINANT PROTEIN; SEMAPHORIN; SUBSTANCE P; TRPV1 PROTEIN, MOUSE; UBIQUITIN THIOLESTERASE; VANILLOID RECEPTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANIMAL; ARTICLE; BLADDER; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; IMMUNOLOGY; INFLAMMATION; METABOLISM; MOUSE; NERVE CELL PLASTICITY; PATHOLOGY; SIGNAL TRANSDUCTION; UROTHELIUM;

ANIMALS; ANTIBODIES, NEUTRALIZING; BCG VACCINE; CALCITONIN; FEMALE; INFLAMMATION; MICE; MICE, INBRED C57BL; NEURONAL PLASTICITY; NEUROPILIN-1; NEUROPILIN-2; NEUROPILINS; PROTEIN PRECURSORS; RECOMBINANT PROTEINS; SEMAPHORINS; SIGNAL TRANSDUCTION; SUBSTANCE P; TRPV CATION CHANNELS; UBIQUITIN THIOLESTERASE; URINARY BLADDER; UROTHELIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80355131520     PISSN: None     EISSN: 14726793     Source Type: Journal    
DOI: 10.1186/1472-6793-11-16     Document Type: Article

References (65)

1. TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications. Avelino A, Cruz F, Naunyn Schmiedebergs Arch Pharmacol 2006 373 4 287 299 10.1007/s00210-006-0073-2 16721555 (Pubitemid 43999780)
2. Pharmacologic perspective on the physiology of the lower urinary tract. Andersson KE, Hedlund P, Urology 2002 60 5 Suppl 1 13 20 discussion 20-11 12493344
3. ATP and P2X purinoceptors in urinary tract disorders. Ford AP, Cockayne DA, Handb Exp Pharmacol 2011 202 485 526
4. Neurokinin-1 (NK-1) receptor is required in antigen-induced cystitis. Saban R, Saban MR, Nguyen NB, Lu B, Gerard C, Gerard NP, Hammond TG, Am J Pathol 2000 156 3 775 780 10.1016/S0002-9440(10)64944-9 10702392 (Pubitemid 30626934)
5. Mandatory role of proteinase-activated receptor 1 in experimental bladder inflammation. Saban R, D'Andrea MR, Andrade-Gordon P, Derian CK, Dozmorov I, Ihnat MA, Hurst RE, Davis CA, Simpson C, Saban MR, BMC Physiol 2007 7 4 10.1186/1472-6793-7-4 17397548 (Pubitemid 46633740)
6. Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function. Schnegelsberg B, Sun TT, Cain G, Bhattacharya A, Nunn PA, Ford AP, Vizzard MA, Cockayne DA, Am J Physiol Regul Integr Comp Physiol 2010 298 3 534 547 10.1152/ajpregu.00367.2009 20032263
7. Origins of the neurovascular bundle: interactions between developing nerves and blood vessels in embryonic chick skin. Martin P, Lewis J, Int J Dev Biol 1989 33 3 379 387 2702122 (Pubitemid 19281603)
8. Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Mukouyama YS, Shin D, Britsch S, Taniguchi M, Anderson DJ, Cell 2002 109 6 693 705 10.1016/S0092-8674(02)00757-2 12086669 (Pubitemid 34722266)
9. Enhancement of sciatic-nerve regeneration after VEGF gene therapy. Pereira Lopes FR, Lisboa BC, Frattini F, Almeida FM, Tomaz MA, Matsumoto PK, Langone F, Lora S, Melo PA, Borojevic R, Han SW, Martinez AM, Neuropathol Appl Neurobiol 2011
10. Common mechanisms of nerve and blood vessel wiring. Carmeliet P, Tessier-Lavigne M, Nature 2005 436 7048 193 200 10.1038/nature03875 16015319 (Pubitemid 41021263)
11. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Yuan L, Moyon D, Pardanaud L, Breant C, Karkkainen MJ, Alitalo K, Eichmann A, Development 2002 129 20 4797 4806 12361971 (Pubitemid 35282411)
12. Role and therapeutic potential of VEGF in the nervous system. Ruiz de Almodovar C, Lambrechts D, Mazzone M, Carmeliet P, Physiol Rev 2009 89 2 607 648 10.1152/physrev.00031.2008 19342615
13. Neuropilins in neoplasms: expression, regulation, and function. Bielenberg DR, Pettaway CA, Takashima S, Klagsbrun M, Exp Cell Res 2006 312 5 584 593 10.1016/j.yexcr.2005.11.024 16445911 (Pubitemid 43290335)
14. Semaphorins and their receptors in immune cell interactions. Suzuki K, Kumanogoh A, Kikutani H, Nat Immunol 2008 9 1 17 23 10.1038/ni1553 18087252 (Pubitemid 350286199)
15. Axon guidance molecules in vascular patterning. Adams RH, Eichmann A, Cold Spring Harb Perspect Biol 2010 2 5 001875 10.1101/cshperspect.a001875 20452960
16. Plexin-A4-semaphorin 3A signaling is required for Toll-like receptor- and sepsis-induced cytokine storm. Wen H, Lei Y, Eun SY, Ting JP, J Exp Med 2010 207 13 2943 2957 10.1084/jem.20101138 21098092
17. Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III. Chen H, Chedotal A, He Z, Goodman CS, Tessier-Lavigne M, Neuron 1997 19 3 547 559 10.1016/S0896-6273(00)80371-2 9331348 (Pubitemid 27430744)
18. Neuropilin-2 is a receptor for semaphorin IV: insight into the structural basis of receptor function and specificity. Giger RJ, Urquhart ER, Gillespie SK, Levengood DV, Ginty DD, Kolodkin AL, Neuron 1998 21 5 1079 1092 10.1016/S0896-6273(00)80625-X 9856463 (Pubitemid 29018077)
19. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M, Cell 1998 92 6 735 745 10.1016/S0092-8674(00)81402-6 9529250 (Pubitemid 28155313)
20. Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II. Takamatsu H, Takegahara N, Nakagawa Y, Tomura M, Taniguchi M, Friedel RH, Rayburn H, Tessier-Lavigne M, Yoshida Y, Okuno T, Mizui M, Kang S, Nojima S, Tsujimura T, Nakatsuji Y, Katayama I, Toyofuku T, Kikutani H, Kumanogoh A, Nat Immunol 2010 11 7 594 600 10.1038/ni.1885 20512151
21. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. Xu Y, Yuan L, Mak J, Pardanaud L, Caunt M, Kasman I, Larrivee B, Del Toro R, Suchting S, Medvinsky A, Silva J, Yang J, Thomas JL, Koch AW, Alitalo K, Eichmann A, Bagri A, J Cell Biol 2010 188 1 115 130 10.1083/jcb.200903137 20065093
22. Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients. Saban R, Saban MR, Maier J, Fowler B, Tengowski M, Davis CA, Wu XR, Culkin DJ, Hauser P, Backer J, Hurst RE, Am J Physiol Renal Physiol 2008 295 6 1613 1623 10.1152/ajprenal.90344.2008 18815217
23. VEGF receptors and neuropilins are expressed in the urothelial and neuronal cells in normal mouse urinary bladder and are upregulated in inflammation. Saban MR, Backer JM, Backer MV, Maier J, Fowler B, Davis CA, Simpson C, Wu XR, Birder L, Freeman MR, Soker S, Hurst RE, Saban R, Am J Physiol Renal Physiol 2008 295 1 60 72 10.1152/ajprenal.00618.2007 18463314
24. Peripheral nerve regeneration is delayed in neuropilin 2-deficient mice. Bannerman P, Ara J, Hahn A, Hong L, McCauley E, Friesen K, Pleasure D, J Neurosci Res 2008 86 14 3163 3169 10.1002/jnr.21766 18615644
25. The semaphorins. Yazdani U, Terman JR, Genome Biol 2006 7 3 211 10.1186/gb-2006-7-3-211 16584533 (Pubitemid 44774190)
26. Semaphorin III can repulse and inhibit adult sensory afferents in vivo. Tanelian DL, Barry MA, Johnston SA, Le T, Smith GM, Nat Med 1997 3 12 1398 1401 10.1038/nm1297-1398 9396612 (Pubitemid 28011042)
27. Intrathecally administered Sema3A protein attenuates neuropathic pain behavior in rats with chronic constriction injury of the sciatic nerve. Hayashi M, Kamiya Y, Itoh H, Higashi T, Miyazaki T, Funakoshi K, Yamashita N, Goshima Y, Andoh T, Yamada Y, Goto T, Neurosci Res 2011 69 1 17 24 10.1016/j.neures.2010. 09.006 20888378
28. Semaphorin III can function as a selective chemorepellent to pattern sensory projections in the spinal cord. Messersmith EK, Leonardo ED, Shatz CJ, Tessier-Lavigne M, Goodman CS, Kolodkin AL, Neuron 1995 14 5 949 959 10.1016/0896-6273(95)90333-X 7748562
29. Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages. Ji JD, Park-Min KH, Ivashkiv LB, Hum Immunol 2009 70 4 211 217 10.1016/j.humimm.2009.01.026 19480842
30. Blood vessels and nerves: common signals, pathways and diseases. Carmeliet P, Nat Rev Genet 2003 4 9 710 720 10.1038/nrg1158 12951572 (Pubitemid 37046138)
31. Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Favier B, Alam A, Barron P, Bonnin J, Laboudie P, Fons P, Mandron M, Herault JP, Neufeld G, Savi P, Herbert JM, Bono F, Blood 2006 108 4 1243 1250 10.1182/blood-2005-11-4447 16621967 (Pubitemid 44232021)
32. BCG-induced urinary cytokines inhibit microvascular endothelial cell proliferation. Pavlovich CP, Kraling BM, Stewart RJ, Chen X, Bochner BH, Luster AD, Poppas DP, O'Donnell MA, J Urol 2000 163 6 2014 2021 10.1016/S0022-5347(05) 67620-3 10799249 (Pubitemid 30366804)
33. Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG). Saban MR, Simpson C, Davis C, Wallis G, Knowlton N, Frank MB, Centola M, Gallucci RM, Saban R, BMC immunology 2007 8 6 10.1186/1471-2172-8-6 17506885 (Pubitemid 46938935)
34. IL-17 and VEGF are necessary for efficient corneal nerve regeneration. Li Z, Burns AR, Han L, Rumbaut RE, Smith CW, Am J Pathol 2011 178 3 1106 1116 10.1016/j.ajpath.2010.12.001 21356362
35. Functional transient receptor potential vanilloid 1 is expressed in human urothelial cells. Charrua A, Reguenga C, Cordeiro JM, Correiade-Sa P, Paule C, Nagy I, Cruz F, Avelino A, J Urol 2009 182 6 2944 2950 10.1016/j.juro.2009.08. 022 19846148
36. Isolation of PGP 9.5, a new human neurone-specific protein detected by high-resolution two-dimensional electrophoresis. Doran JF, Jackson P, Kynoch PA, Thompson RJ, J Neurochem 1983 40 6 1542 1547 10.1111/j.1471-4159.1983.tb08124.x 6343558 (Pubitemid 13106931)
37. GRC-6211, a new oral specific TRPV1 antagonist, decreases bladder overactivity and noxious bladder input in cystitis animal models. Charrua A, Cruz CD, Narayanan S, Gharat L, Gullapalli S, Cruz F, Avelino A, J Urol 2009 181 1 379 386 10.1016/j.juro.2008.08.121 19010489
38. Neuro-vascular link: from genetic insights to therapeutic perspectives. Carmeliet P, Bull Mem Acad R Med Belg 2008 163 10-12 445 451 discussion 451-442 20120252
39. Targeting neuropilin-1 to inhibit VEGF signaling in cancer: Comparison of therapeutic approaches. Mac Gabhann F, Popel AS, PLoS Comput Biol 2006 2 12 180 10.1371/journal.pcbi.0020180 17196035 (Pubitemid 46045177)
40. Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle. Mac Gabhann F, Popel AS, Am J Physiol Heart Circ Physiol 2007 292 1 459 474 16980341
41. A neurotrophin signaling cascade coordinates sympathetic neuron development through differential control of TrkA trafficking and retrograde signaling. Kuruvilla R, Zweifel LS, Glebova NO, Lonze BE, Valdez G, Ye H, Ginty DD, Cell 2004 118 2 243 255 10.1016/j.cell.2004.06.021 15260993 (Pubitemid 38962579)
42. Possible mechanisms inducing glomerulations in interstitial cystitis: relationship between endoscopic findings and expression of angiogenic growth factors. Tamaki M, Saito R, Ogawa O, Yoshimura N, Ueda T, J Urol 2004 172 3 945 948 10.1097/01.ju.0000135009.55905.cb 15311005 (Pubitemid 39096430)
43. Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice. Kim CF, Moalem-Taylor G, J Pain 2011 12 3 370 383 20889388
44. Hyperalgesia due to nerve injury: role of neutrophils. Perkins NM, Tracey DJ, Neuroscience 2000 101 3 745 757 10.1016/S0306-4522(00)00396-1 11113323
45. Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Sarris M, Andersen KG, Randow F, Mayr L, Betz AG, Immunity 2008 28 3 402 413 10.1016/j.immuni.2008.01.012 18328743
46. Neuropilin-1: the glue between regulatory T cells and dendritic cells? Mizui M, Kikutani H, Immunity 2008 28 3 302 303 10.1016/j.immuni.2008.02.012 18342004 (Pubitemid 351335314)
47. Neuropilin-1: a surface marker of regulatory T cells. Bruder D, Probst-Kepper M, Westendorf AM, Geffers R, Beissert S, Loser K, von Boehmer H, Buer J, Hansen W, Eur J Immunol 2004 34 3 623 630 10.1002/eji.200324799 14991591 (Pubitemid 39255909)
48. Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer. Battaglia A, Buzzonetti A, Monego G, Peri L, Ferrandina G, Fanfani F, Scambia G, Fattorossi A, Immunology 2008 123 1 129 138 10.1111/j.1365-2567.2007.02737.x 18028372 (Pubitemid 350256004)
49. Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer. Muller MW, Giese NA, Swiercz JM, Ceyhan GO, Esposito I, Hinz U, Buchler P, Giese T, Buchler MW, Offermanns S, Friess H, Int J Cancer 2007 121 11 2421 2433 10.1002/ijc.22949 17631638 (Pubitemid 350022411)
50. VEGF-A and Semaphorin3A: modulators of vascular sympathetic innervation. Long JB, Jay SM, Segal SS, Madri JA, Dev Biol 2009 334 1 119 132 10.1016/j.ydbio.2009.07.023 19631637
51. Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis. Brockington A, Wharton SB, Fernando M, Gelsthorpe CH, Baxter L, Ince PG, Lewis CE, Shaw PJ, J Neuropathol Exp Neurol 2006 65 1 26 36 10.1097/01.jnen.0000196134.51217.74 16410746
52. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. Ogunshola OO, Antic A, Donoghue MJ, Fan SY, Kim H, Stewart WB, Madri JA, Ment LR, J Biol Chem 2002 277 13 11410 11415 10.1074/jbc.M111085200 11777931 (Pubitemid 34952908)
53. Vascular endothelial-derived semaphorin 3 inhibits sympathetic axon growth. Damon DH, Am J Physiol Heart Circ Physiol 2006 290 3 1220 1225 16258027
54. VEGF promotes vascular sympathetic innervation. Marko SB, Damon DH, Am J Physiol Heart Circ Physiol 2008 294 6 2646 2652 10.1152/ajpheart.00291.2008 18408130
55. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Niknejad K, Peoples GE, Klagsbrun M, Cancer Res 1995 55 18 4140 4145 7545086
56. Neuropilin-VEGF signaling pathway acts as a key modulator of vascular, lymphatic, and inflammatory cell responses of the bladder to intravesical BCG treatment. Saban MR, Sferra TJ, Davis CA, Simpson C, Allen A, Maier J, Fowler B, Knowlton N, Birder L, Wu XR, Saban R, Am J Physiol Renal Physiol 2010 299 6 1245 1256 10.1152/ajprenal.00352.2010 20861073
57. Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding. Appleton BA, Wu P, Maloney J, Yin J, Liang WC, Stawicki S, Mortara K, Bowman KK, Elliott JM, Desmarais W, Bazan JF, Bagri A, Tessier-Lavigne M, Koch AW, Wu Y, Watts RJ, Wiesmann C, Embo J 2007 26 23 4902 4912 10.1038/sj.emboj.7601906 17989695 (Pubitemid 350191304)
58. Semaphorin-neuropilin interactions underlying sympathetic axon responses to class III semaphorins. Chen H, He Z, Bagri A, Tessier-Lavigne M, Neuron 1998 21 6 1283 1290 10.1016/S0896-6273(00)80648-0 9883722 (Pubitemid 29022531)
59. Proliferating endothelial cells, but not microvessel density, are a prognostic parameter in human cutaneous melanoma. Hillen F, van de Winkel A, Creytens D, Vermeulen AH, Griffioen AW, Melanoma Res 2006 16 5 453 457 10.1097/01.cmr.0000232291.68666.4c 17013095 (Pubitemid 44511226)
60. A light- and electron-microscopic histopathological study of human bladder mucosa after intravesical resiniferatoxin application. Silva C, Avelino A, Souto-Moura C, Cruz F, BJU Int 2001 88 4 355 360 10.1046/j.1464-410X.2001. 02339.x 11564021 (Pubitemid 34066072)
61. Plasticity and regeneration in the peripheral nervous system. Geuna S, Fornaro M, Raimondo S, Giacobini-Robecchi MG, Ital J Anat Embryol 2010 115 1-2 91 94 21072996
62. Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library. Liang WC, Dennis MS, Stawicki S, Chanthery Y, Pan Q, Chen Y, Eigenbrot C, Yin J, Koch AW, Wu X, Ferrara N, Bagri A, Tessier-Lavigne M, Watts RJ, Wu Y, J Mol Biol 2007 366 3 815 829 10.1016/j.jmb.2006.11.021 17196977 (Pubitemid 46175863)
63. Structure-function studies of two synthetic anti-vascular endothelial growth factor Fabs and comparison with the Avastin Fab. Fuh G, Wu P, Liang WC, Ultsch M, Lee CV, Moffat B, Wiesmann C, J Biol Chem 2006 281 10 6625 6631 10.1074/jbc.M507783200 16373345 (Pubitemid 43847597)
64. Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Pan Q, Chanthery Y, Liang WC, Stawicki S, Mak J, Rathore N, Tong RK, Kowalski J, Yee SF, Pacheco G, Ross S, Cheng Z, Le Couter J, Plowman G, Peale F, Koch AW, Wu Y, Bagri A, Tessier-Lavigne M, Watts RJ, Cancer Cell 2007 11 1 53 67 10.1016/j.ccr.2006.10.018 17222790 (Pubitemid 46054517)
65. Expression of transient receptor potential c6 channels in human lung macrophages. Finney-Hayward TK, Popa MO, Bahra P, Li S, Poll CT, Gosling M, Nicholson AG, Russell RE, Kon OM, Jarai G, Westwick J, Barnes PJ, Donnelly LE, American journal of respiratory cell and molecular biology 2010 43 3 296 304 10.1165/rcmb.2008-0373OC 19843708